SULLIVAN TIMOTHY EUGENE (Chief Financial Officer) sold 9.9% of their position (10.29K shares) of APELLIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $223.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2026ACC: 0001492422-26-000055
Officer· Chief Financial Officer
Since Feb 2019
-10.29K
Net shares
Net seller
$223.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.29K
Price / share
$21.77
Trade value
$223.90K
% of position
9.9%
1/22/2026
104.19K→93.90K
Total
Net shares
−10.29K
Net value
-$223.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | S · Sale | −10.29K | $21.77 | $223.90K | 9.9% | 104.19K | 93.90K |
| Total | −10.29K | -$223.90K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned60.40K
Total
60.40K indirect60.40K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 60.40K | Indirect |
| Total | 60.40K | 60.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported